STEMCELL Technologies has commercially launched the CellPore Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the...
Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for suzetrigine, an investigational, oral,...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced that Molecular Pathology Laboratory Network, Inc., (MPLN) is now the first national molecular reference...
GSK plc and Flagship Pioneering (Flagship), the bioplatform innovation company, announced they have entered a collaboration with the goal of discovering and developing a...
Amneal Pharmaceuticals, Inc. announced that it has received New Drug Application (“NDA”) approval from the U.S. Food and Drug Administration (FDA) for its new...
